期刊文献+

白细胞介素29抑制破骨细胞分化的研究

Inhibitory effect of interleukin 29 on osteoclast differentiation
下载PDF
导出
摘要 目的 :新型细胞因子白细胞介素(interleukin,IL)-29具有抗病毒、抗肿瘤、免疫调节等作用,但其在破骨细胞分化中的作用尚未见报道。本研究探讨IL-29对核因子κB受体活化因子配基(receptor activation of nuclear-κB ligand,RANKL)诱导小鼠巨噬细胞RAW264.7(破骨前体细胞)向破骨细胞分化的作用。方法:流式检测IL-29特异性受体IL-28Rα在RAW264.7细胞表面的表达,CCK8法检测IL-29对RAW264.7细胞增殖的影响。不同浓度IL-29重组因子加入到RANKL诱导的RAW264.7向破骨细胞分化的体系中,5 d后通过抗酒石酸酸性磷酸酶染色检测IL-29对破骨细胞数目的影响。实时荧光定量PCR检测IL-29对破骨细胞标志性基因TRAP、CTR、CTSK及相关基因TRAF6、RANK表达的影响。结果 :IL-29呈剂量依赖性抑制RANKL诱导的RAW264.7中破骨细胞的形成,100 ng/m L IL-29可显著抑制破骨细胞的形成以及破骨细胞形成相关基因TRAP、CTR、CTSK、TRAF6、RANK的表达。结论 :本研究首次证实IL-29可以抑制破骨细胞形成及其功能。 Objective:The novel cytokine interleukin(IL)-29 has been reported to induce antiviral, antitumor, and immune responses. However,the effect of IL-29 on osteoclast differentiation remains unclear. This study aimed to explore the effect of IL-29 on osteoclast differentiation and function in RANKL-induced in RAW264.7 cells(osteoclast precursors). Methods:The expression of IL-28Rα(specific receptor of IL-29) on RAW264.7 cells was evaluated by flow cytometry. RAW264.7 cells were stimulated with RANKL and different doses of recombinant IL-29 for 5 d,then the osteoclast formation was evaluated by counting multinucleated cells for tartrate-resistant acid phosphatase(TRAP) staining. Furthermore,the effect of IL-29 on the RANKL-induced expression of osteoclastic genes(TRAP,CTR and CTSK) and relevant genes(TRAF6 and RANK) was detected by real time PCR. Results:IL-29 inhibited the osteoclast formation in a dose-dependent manner in RANKL-induced RAW264.7 cells,and the dose of 100 ng / ml IL-29 significantly reduced the number of TRAP positive multinucleated cells and m RNA expression of osteoclastic genes(TRAP,CTR and CTSK) and relevant genes(TRAF6 and RANK). Conclusion:The findings in the present study indicate,for the first time,that IL-29 could inhibit osteoclast formation and function.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2016年第3期313-317,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81471610 81471611)
关键词 白细胞介素29 破骨细胞 类风湿关节炎 interleukin 29 osteoclast rheumatoid arthritis
  • 相关文献

参考文献16

  • 1Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambda s mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex[ J ]. Nat Immunol, 2003, d (1) : 69-77.
  • 2Megjugorac NJ, Gallagher GE, Gallagher G. Modulation of human plasmacytoid DC function by IFN-lambdal (IL- 29) [J]. J Leukoc Biol, 2009,86(6) : 1359-1363.
  • 3Xu LX, Feng XK, Tan WF, et al. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the syn- ovial fibroblasts from rheumatoid arthritis patients [J].Arthritis Res Ther,2013,15(5) :R170.
  • 4Liu BS,Janssen HL,Boonstra A. IL-29 and IFN alpha differ in their ability to modulate IL-12 production by TLR-ac- tivated human macrophages and exhibit differential regu- lation of the IFN gamma receptor expression[J]. Blood, 2011,117(8) :2385-2395.
  • 5Muir AJ,Shiffman ML,Zaman A,et al. Phase lb study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infec- tion[J]. Hepatology, 2010,52(3) : 822-832.
  • 6Lasfar A, Abushahba W, Balan M, et al. Interferon lamb- da:a new sword in cancer immunotherapy[J]. Clin Dev Immunol,2011,2011 : 349575.
  • 7Groen RA,Boltjes A,Hou J,et al. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK ceils [ J ]. Eur J Immunol, 2015,45 ( 1 ) : 250- 259.
  • 8Wolk K,Witte K,Witte E,et al. IL-29 is produced by TH17 cells and mediates the cutaneous antiviral compe- tence in psoriasis[J]. Sci Transl Med,2013,5 (204): 204ra 129.
  • 9Schett G,Gravallese E. Bone erosion in rheumatoid arthri- tis:mechanisms,diagnosis and treatment[J]. Nat Rev Rheumatol, 2012,8 (11) : 656-664.
  • 10Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions [J]. J Dent Res, 2013,92(10) : 860-867 Danks L,Takayanagi H. Immunology and bone[J]. J Biochem, 2013,154( 1 ) : 29-39.

二级参考文献17

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部